Eurordis

Eurordis

We were charged with securing broadcast coverage on behalf of our pharmaceutical client’s involvement in the treatment of rare diseases.

During European Rare Diseases Day, we secured coverage on Channel 4 News, having presented the national media with a case study involving a patient with Fabry disease. Our intimate understanding of the broadcast news landscape – their needs and working practices – as well as our contacts there – were key to securing this important awareness-raising coverage. Our team has since worked in the rare disease niche, specifically on a project concerning implementation of the European Cross Border Healthcare Directive, and its relevance to patients as well as doctors, surgeons, and other healthcare professionals.